DataMeds AI, Inc. (MEDS) stock
MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
$0.64−0.00 (-0.28%)
Close on Nov 17, 2026Market cap $1.96MP/E –Yield –
DataMeds AI gross margin
Gross margin is gross profit as a percentage of revenue.
DataMeds AI's gross margin for the twelve months ending Sep 30, 2026 was -92.1%. For fiscal 2025 it was -27.5%, against 9.7% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -27.5% | −37.3 |
| FY2024 | Dec 31, 2024 | 9.7% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 16.2% | +8.5 |
| Q2 FY2026 | Jun 30, 2026 | 10.2% | +3.7 |
| Q1 FY2026 | Mar 31, 2026 | 10.9% | +4.5 |
| Q4 FY2025 | Dec 31, 2025 | -470.2% | −480.3 |
| Q3 FY2025 | Sep 30, 2025 | 7.7% | −1.5 |
| Q2 FY2025 | Jun 30, 2025 | 6.5% | +12.3 |
| Q1 FY2025 | Mar 31, 2025 | 6.4% | – |
| Q4 FY2024 | Dec 31, 2024 | 10.1% | – |
| Q3 FY2024 | Sep 30, 2024 | 9.2% | – |
| Q2 FY2024 | Jun 30, 2024 | -5.9% | – |
See a number that looks wrong?